S. Korea Study Finds No Added Pregnancy Risk From Antibiotics, Tylenol
This article was originally published in PharmAsia News
Executive Summary
A South Korean study has concluded that taking antibiotics and painkillers in the early stages of pregnancy has almost no effect on the risk of having a deformed child. A team of scientists studied pregnant women exposed to ampicillin and Ortho McNeill Jansen's Tylenol (acetaminophen) between 3.5 and 4.6 weeks of pregnancy and compared outcomes with unexposed mothers-to-be and found no statistically differences between the two groups in giving birth to congenitally malformed offspring. The same study also found the dosages did not create a statistically different risk of premature births, underweight children or miscarriages. (Click here for more
You may also be interested in...
California Bill To Age-Restrict Sales Of Diet Pills Further Along Than Other States’ Legislation
CA, MA and NJ legislatures remain in session with bills active proposing regulations similar to NY law effective 22 April requiring retailers, including online, to ask for proof of age when customers buying consumer health products containing ingredients labeled or promoted for weight loss and bodybuilding benefits appear younger than 18.
CRN Has Standing For Steep Hill To Climb Challenging New York's Age-Restricted Sales
Federal judge finds “misreading of the legislation” in CRN’s argument that state “restricts access based purely on what has been said about the product or its ingredients.” But standing to challenge “means that only CRN is positioned right now to go before the court on behalf of industry,” says CEO Steve Mister.
Addition to Quest Alzheimer's Suite Looks For Biomarker P-Tau217
The test is being integrated into Quest’s AD-Detect portfolio for assessing the risk of Alzheimer’s. It is the third p-tau217 test to make news this month, after new breakthrough designations for Quanterix and Roche and Eli Lilly.